To: President Donald Trump, The United States House of Representatives, and The United States Senate

Explain discrepancies in marijuana stance.

We, the public, want to know why, despite holding a patent that outlines all the benefits of cannibis, the FDA still insists it is a Schedule1 drug?

Why is this important?

While the government insists that cannibis needs to remain a Schedule1 drug, it simultaneously holds patent #6,630,507 which clearly outlines all the medical benefits of the herb. The people deserve an explanation regarding these contradicting stances.